S2k Guidelines for the diagnosis and treatment of chronic pruritus - update - short version

J Dtsch Dermatol Ges. 2017 Aug;15(8):860-872. doi: 10.1111/ddg.13304.

Abstract

Associated with a host of different diseases, pruritus is a cardinal symptom that poses an interdisciplinary diagnostic and therapeutic challenge. Over time, that symptom may progress independently of the initial cause, thus losing its function as a warning sign and turning into a clinically relevant disease of its own. In Germany, approximately 13.5 % of the general population are affected by chronic pruritus, with an incidence of 7 %. All forms of chronic pruritus require targeted treatment consisting of (a) diagnosis and management of the underlying disease, (b) dermatological treatment of primary or secondary (for example, dry skin, scratch lesions) symptoms, (c) symptomatic antipruritic treatment, and (d) psychological/psychotherapeutic treatment in case of an underlying or associated psychological or psychosomatic condition. Medical care of patients with chronic pruritus should therefore include an interdisciplinary approach, in particular with respect to diagnosis and therapy of the underlying disease as well as in terms of the management of treatment and adverse events. The objective of the present interdisciplinary guidelines is to define and standardize diagnostic and therapeutic procedures in patients with chronic pruritus. This is a short version of the current S2 guidelines on chronic pruritus. The long version may be found at www.awmf.org.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Antipruritics / therapeutic use
  • Chronic Disease
  • Combined Modality Therapy
  • Cross-Sectional Studies
  • Disease Progression
  • Germany
  • Interdisciplinary Communication
  • Intersectoral Collaboration
  • Pruritus / diagnosis*
  • Pruritus / epidemiology
  • Pruritus / etiology
  • Pruritus / therapy*
  • Psychotherapy

Substances

  • Antipruritics